Recommended Antidepressant for Depression, Anxiety, and Poor Sleep
For an adult female with depression, anxiety, and insomnia, mirtazapine is the recommended antidepressant based on its unique pharmacological profile that directly addresses all three symptom domains simultaneously.
Primary Recommendation: Mirtazapine
Mirtazapine stands out as the optimal choice because it:
- Treats depression effectively with efficacy comparable to SSRIs and other second-generation antidepressants 1
- Reduces anxiety symptoms as effectively as other antidepressants 1
- Significantly improves sleep by shortening sleep-onset latency, increasing total sleep time, and improving sleep efficiency 2
The drug works through a dual mechanism as a noradrenergic and specific serotonergic antidepressant (NaSSA), blocking 5-HT2 and 5-HT3 receptors while enhancing norepinephrine and 5-HT1A-mediated serotonergic transmission 3. This 5-HT2 receptor blockade is specifically what alleviates insomnia and improves sleep architecture 2.
Starting dose: 15 mg at bedtime 4
Why Not Other Options?
SSRIs (Sertraline, Fluoxetine, Paroxetine)
While SSRIs effectively treat depression and anxiety 1, they stimulate 5-HT2 receptors, which worsens insomnia and disrupts sleep architecture 2. This is why hypnotics or low-dose trazodone are commonly co-prescribed with SSRIs 2—but this creates polypharmacy when a single agent could address all symptoms.
Trazodone
Despite widespread off-label use for insomnia, the 2017 American Academy of Sleep Medicine guidelines explicitly recommend AGAINST using trazodone for sleep onset or maintenance insomnia 5. The evidence base is weak 6, and it lacks robust data for treating the full depression syndrome 4.
Low-Dose Doxepin
While doxepin (3-6 mg) is recommended for sleep maintenance insomnia 5, these doses are insufficient to treat major depression 6. You would need higher doses for antidepressant effects, which increases anticholinergic burden 4.
Clinical Algorithm
Step 1: Start mirtazapine 15 mg at bedtime
- Expect sleep improvement within days to 1 week
- Antidepressant effects typically emerge within 1-2 weeks (faster onset than SSRIs) 3
Step 2: Assess response at 2-4 weeks
- If partial response: increase to 30 mg at bedtime
- If no response: consider switching to different antidepressant class
Step 3: If insomnia persists despite adequate antidepressant response
- Add cognitive behavioral therapy for insomnia (CBT-I), which is the gold standard non-pharmacological treatment 6
- Consider adding a benzodiazepine receptor agonist (eszopiclone 2-3 mg, zolpidem 10 mg) 6, 5
Important Caveats
Weight gain and sedation are the primary concerns with mirtazapine 7, 3. However, these side effects can be advantageous for patients with depression-related weight loss and insomnia 7. The sedation typically improves sleep rather than causing problematic daytime drowsiness when dosed at bedtime.
Contraindications to consider:
- Avoid if patient is concerned about weight gain
- Use caution in elderly (start lower dose, monitor for falls)
- Not recommended during pregnancy or nursing 6
Drug interactions: Mirtazapine is metabolized by CYP1A2, CYP2D6, and CYP3A4, but in vitro studies suggest it's unlikely to cause clinically significant drug-drug interactions 3.
Alternative if Mirtazapine is Contraindicated
If weight gain is unacceptable, consider sertraline (starting 50 mg daily) for depression and anxiety 1, 7, combined with a benzodiazepine receptor agonist like eszopiclone (2-3 mg at bedtime) for insomnia 6, 5. This two-drug approach is supported by guidelines when sedating antidepressants cannot be used 6.
The combination approach is explicitly mentioned in the 2008 AASM guidelines as appropriate when treating comorbid depression/anxiety with insomnia 6, though it requires managing two medications instead of one.